Numerous studies have shown that DAB2 acts as an oncogenic factor to inhibit tumor cell proliferation in the early tumor stage, but in the late tumor stage, DAB2 promotes tumor cell EMT and invasion leading to metastasis. Here, DAB2 is linked to neoplasm.